Back | Next |
home / stock / bmy / bmy message board
Subject | By | Source | When |
---|---|---|---|
$BMY 4Q22 CC transcript: | DewDiligence | investorshub | 02/02/2023 9:11:27 PM |
$BMYs Sotyktu patients are coming approximately 1/3 from | DewDiligence | investorshub | 02/02/2023 2:23:42 PM |
$BMY 4Q22 CC slides: | DewDiligence | investorshub | 02/02/2023 2:06:28 PM |
$BMY 4Q22 results2023 guidance: | DewDiligence | investorshub | 02/02/2023 1:26:59 PM |
CHMP approves $BMYs Sotyktu for psoriasis: | DewDiligence | investorshub | 01/27/2023 3:29:27 PM |
AddendumBreyanzi is the first CAR-T to show efficacy | DewDiligence | investorshub | 01/27/2023 12:54:38 AM |
$BMYs Breyanzi meets primary endpoint in rrCLL/SLL single-arm trial: | DewDiligence | investorshub | 01/26/2023 3:45:51 PM |
whytestocks: $BMY News Article - The Robert A. Winn Diversity in Clinical Trials Award Program Estab | whytestocks | investorshangout | 01/19/2023 5:50:46 PM |
$BMYs$ JPM webcast slides: | DewDiligence | investorshub | 01/09/2023 3:40:36 PM |
$BMYs Breyanzi continues to show robust results in | DewDiligence | investorshub | 12/12/2022 4:53:55 PM |
$BMYs ASH presentations: | DewDiligence | investorshub | 12/12/2022 2:54:46 PM |
$BMY boosts annualized dividend to $2.28(from $2.16): | DewDiligence | investorshub | 12/08/2022 10:38:14 PM |
whytestocks: $BMY News Article - Bristol Myers Squibb Data at ASH 2022 Highlight Innovative Therapeu | whytestocks | investorshangout | 11/21/2022 7:15:50 PM |
$BMYs ASH lineup: | DewDiligence | investorshub | 11/21/2022 2:44:19 PM |
$BMYs AHA presentation lineup: | DewDiligence | investorshub | 11/02/2022 1:04:58 PM |
$BMY scores phase-3 win for Reblozyl in a | DewDiligence | investorshub | 10/31/2022 3:45:41 PM |
$BMY 3Q22 CC transcript: | DewDiligence | investorshub | 10/26/2022 8:36:28 PM |
$BMY 3Q22 CC slides: | DewDiligence | investorshub | 10/26/2022 11:59:17 AM |
$BMY 3Q22 results2022 non-GAAP guidance unchanged: | DewDiligence | investorshub | 10/25/2022 11:48:51 PM |
Camzyos sNDA for prevention of SRT* in patients | DewDiligence | investorshub | 10/21/2022 12:48:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Bristol-Myers Squibb Company Company Name:
BMY Stock Symbol:
NYSE Market:
2024-05-03 09:30:00 ET Some investors view growth or momentum stocks as the key to multi-bagger returns. Others prefer to deep-sea dive for beaten-down assets with rebound potential. The compounding effect of dividend reinvestment over enough time can potentially make it possible to turn $1...
2024-05-03 07:15:00 ET It's a reasonable question: If you'd invested $1,000 in pharmaceutical specialist Bristol Myers Squibb (NYSE: BMY) five years ago in 2019, how much would you have today? You might ask that if you've been thinking of investing in the company or holding its ...
CAMBRIDGE, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced a two-year extension to the collaboration with Bristol Myers Squibb (NYSE: BMY) under which the parties may research, develop, and commercialize autologo...